DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) was the target of a significant growth in short interest in December. As of December 31st, there was short interest totalling 54,100 shares, a growth of 14.6% from the December 15th total of 47,200 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 541.0 days.
Wall Street Analysts Forecast Growth
Separately, UBS Group lowered DiaSorin from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 26th.
Get Our Latest Research Report on DiaSorin
DiaSorin Price Performance
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- Why is the Ex-Dividend Date Significant to Investors?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- What does consumer price index measure?
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.